Plenary Sessions and Speakers Announced for ISPOR 20th Annual European Congress

Published Sep 18, 2017

Conference to Explore The Evolution of Value in Health Care on 4-8 November 2017 in Glasgow, Scotland

Princeton, NJ—September 18, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 20th Annual European Congress that will be held 4-8 November 2017 in Glasgow, Scotland, UK. The congress will center on the theme, “The Evolution of Value in Health Care.” Co-chairs for the congress are Andrew Briggs, DPhil, University of Glasgow, Glasgow, Scotland and Maarten IJzerman, PhD, University of Twente, Enschede , The Netherlands. The first plenary session, “Where Is the Value in Value-Based Health Care?,” is scheduled for Monday, 6 November 2017. This plenary will explore value-based health care (VBHC) from a clinical and hospital perspective and discuss the challenges and main differences of VBHC compared with cost-effectiveness analysis from an industrial, health economics, and patient perspective. Plenary speakers include:
  • Moderator: Maarten J. IJzerman, PhD, University of Twente, Enschede, The Netherlands
  • Speaker: Peter Naredi, University of Gothenburg and European CanCer Organization, Brussels, Belgium
  • Speaker: Luke Slawomirski, Organisation for Economic Co-operation and Development, Paris, France
  • Speaker: Bettina Ryll, MD, PhD, Melanoma Patient Network Europe and European Society for Medical Oncology, Uppsala, Sweden
  • Speaker: Maarten Akkerman, Medtronic, Tolochenaz, Switzerland
The second plenary, “Appraising the Appraisers: What Is the Future of Health technology Assessment in Europe?,” will be held Tuesday, 7 November 2017. This plenary will examine how health technology assessment (HTA) processes might be compared and evaluated, including questions such as, “How cost effective are HTA processes?,” “What is the value for money of HTA activities?,” and “Is there a ‘perfect HTA process’ that can serve as  benchmark?”. Plenary speakers include:
  • Moderator: Andrew Briggs, DPhil, University of Glasgow, Glasgow, UK
  • Speaker: Susan Guthrie, PhD, MSci, Rand Europe, Cambridge, UK
  • Speaker: Nicola Allen, PhD, Precision for Value, London, UK
  • Speaker: Zoe Garrett, MPhil, MRes, National Institute for Health and Care Excellence and EUnetHTA, Manchester, UK
The third plenary, “Evolution of Value: Perspectives From Both Sides of the Atlantic,” is scheduled for Wednesday, 8 November 2017. This plenary will feature health economists from the United Kingdom, United States, and France who will discuss how methodological, societal, and political forces have shaped the current valuation of medical technologies and what the future holds for valuation in health. Plenary speakers include:
  • Moderator: Shelby D. Reed, PhD, RPh, Duke University, Durham, NC, USA
  • Speaker: Mandy Ryan, PhD, MSc, College of Life Sciences and Medicine, University of Aberdeen, Aberdeen, UK
  • Speaker: Charles E. Phelps, PhD, University of Rochester, Gualala, CA, USA
  • Speaker: Jerome Wittwer, PhD, Bordeaux University, Bordeaux, France
ISPOR is recognized globally as the leading professional society for health economics and outcomes research (HEOR) and its role in improving health care decisions. The ISPOR 20th Annual European Congress draws more than 5000 health care stakeholders, including health ministries and government offices, health technology assessment bodies, public and private payers, researchers and academicians, and patients and patient advocates. The congress also features the Society’s renowned Essential HEOR Education curriculum of half-day and full-day short courses on 4-5 November 2017. The ISPOR Short Course Program offers 30+ HEOR course topics across 7 tracks. A variety of issue panels, workshops, forums, educational symposia and educational forums, podium presentations, and poster presentations will also be featured. Additional information on the congress can be found at: Congress Information | Registration | Short Course Program |Sponsorship Opportunities | Exhibitor Opportunities | Press

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×